Browsing by Author "Sabugo Siraqyan, María Francisca"

Now showing items 1-7 of 7

    • Cranial versus extracranial involvement in giant cell arteritis: 15 years retrospective cohort analysis 
      Wurmann Kiblisky, Pamela; Karsulovic Cvitanich, Claudio; Sabugo Siraqyan, María Francisca; Hernández Baeza, Claudia; Zamorano Soto, Pedro; Mac-Namara Hidalgo, Macarena (Dove Medical, 2022)
    • Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a ... 
      Sabugo Siraqyan, María Francisca; Liberman Guendelman, Claudio; Niedmann, Juan Pablo; Soto Sáez, Lilian; Cuchacovich Turteltaub, Miguel (SPRINGER, 2008-04)
      SAPHO syndrome is a rare entity that compromises the skeletal system (arthritis-osteitis) and is associated with various dermatological conditions such as palmoplantaris pustulosis (PPP) and acne. We present the case of a ...
    • Papel de los polimorfismos -238 y -308 del promotor del factor de necrosis tumoral alfa en la patogenia y ... 
      Llanos M., Carolina; Soto Sáez, Lilian; Sabugo Siraqyan, María Francisca; Bastías Ch., M. José; Salazar A., Lorena; Aguillón Gutiérrez, Juan Carlos; Cuchacovich Turteltaub, Miguel (Sociedad Médica de Santiago, 2005)
      Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects 0.8% of the world population, it affects the synovial membrane of joints and the clinical presentation encompasses a wide spectrum, ranging from a ...
    • Systemic vasculitis associated with Fasciola hepatica infection 
      Llanos, Carolina; Soto Sáez, Lilian; Sabugo Siraqyan, María Francisca; Gallegos, I.; Valenzuela Letelier, Omar; Verdaguer, J.; Cuchacovich Turteltaub, Miguel (TAYLOR & FRANCIS AS, 2006-04)
      We report the case of a 50-year-old man who presented with systemic vasculitis associated with Fasciola hepatica infection. The patient presented with severe skin, kidney, spleen, ophthalmic, and neurological compromise. ...
    • The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to ... 
      Soto Sáez, Lilian; Sabugo Siraqyan, María Francisca; Catalán Martina, Diego; Wurmann Kiblisky, Pamela; Cermenatti, Tomás; Gatica Rossi, Héctor; Aravena, Octavio; Salazar, Lorena; Aguillón Gutiérrez, Juan Carlos; Cuchacovich Turteltaub, Miguel (Springer, 2011)
      The introduction of antitumor necrosis factor (TNF) agents has improved the outcome for many patients with rheumatoid arthritis (RA). To date, the only replicated genetic predictor of anti-TNF response is the −308 G > ...
    • Tumour necrosis factor (TNF)α -308 G/G promoter polymorphism and TNFα levels correlate with a better response ... 
      Cuchacovich Turteltaub, Miguel; Soto, L.; Edwardes, M.; Gutiérrez, M.; Llanos, C.; Pacheco, D.; Sabugo Siraqyan, María Francisca; Alamo, M.; Fuentealba, C.; Villanueva, L.; Gatica, H.; Schiattino, Irene; Salazar, L.; Catalán Martina, Diego; Valenzuela, O.; Salazar Onfray, Flavio; Aguillón Gutiérrez, Juan Carlos (2006)
      Objective: To investigate the influence of -308 tumour necrosis factor-α (TNFα) promoter polymorphism and circulating TNFα levels in the clinical response to adalimumab treatment in patients with rheumatoid arthritis (RA). ...
    • Uso de rituximab (anticuerpo monoclonal anti-CD20) en lupus eritematoso sistémico refractario a tratamiento: ... 
      Sabugo Siraqyan, María Francisca; Llanos M., Carolina; Soto Sáez, Lilian; Gutiérrez, Jorge; Cuchacovich Turteltaub, Miguel (Sociedad Médica de Santiago, 2005)
      New therapeutic approaches that include depletion of B cells using rituximab, a chimeric monoclonal antibody directed against the B cell specific antigen CD-20 have been developed for the treatment of systemic lupus ...